Exploratory Trial of Immunochemoradiotherapy for Locally Advanced Pancreatic Adenocarcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Granulocyte macrophage colony stimulating factor; Granulocyte-macrophage colony-stimulating factors; Tadalafil; Tertomotide
- Indications Pancreatic cancer
- Focus Adverse reactions
- 12 Apr 2018 Biomarkers information updated
- 13 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Apr 2011 New trial record